Avadel Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAvadel Pharmaceuticals

Avadel Pharmaceuticals(AVDL)

Avadel Pharmaceuticals plc Nasdaq: AVDL, is a specialty pharmaceutical company. Avadel markets products in the hospital and primary care spaces. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Lumryz	Oxybate	2023-05-01	2024-2042	Narcolepsy , Cataplexy

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

pharmacokinetics

,

traumatic brain injuries

,

,

intrinsic sleep disorders

,

sleep initiation and maintenance disorders

,

post-traumatic stress disorders

,

,

major depressive disorder

,

depressive disorder

,

,

,

ventilator weaning

,

,

,

,

essential tremor

,

cerebral amyloid angiopathy

,

familial cerebral amyloid angiopathy

,

myofascial pain syndromes

,

,

,

,

,

sleep wake disorders

,

,

cluster headache

,

,

feeding and eating disorders

,

binge-eating disorder

,

,

disorders of excessive somnolence

,

,

,

idiopathic hypersomnia

,

,

parkinson disease

,

,

chronic fatigue syndrome

,

,

rem sleep behavior disorder

,

mental disorders

,

obstructive sleep apnea

,

sleep apnea syndromes

,

,

substance withdrawal syndrome

,

alzheimer disease

,

,

palliative care

,

,

psychological trauma

,

traumatic stress disorders

,

physiological stress

,

sleep deprivation

,

postoperative complications

,

kidney transplantation

,

,

incisional hernia

,

bipolar disorder

,

autistic disorder

,

,

,

allergic rhinitis

,

,

allergic conjunctivitis

,

liver neoplasms

,

atopic dermatitis

,

,

healthy volunteers/patients

,

,

,

,

,

prostatic neoplasms

,

postoperative nausea and vomiting

,

,

brain neoplasms

,

second primary neoplasms

,

,

treatment-resistant depressive disorder

,

depressive disorder

,

esophageal neoplasms

,

esophageal squamous cell carcinoma

,

hematologic neoplasms

,

,

pseudomonas infections

,

pseudomonas aeruginosa

,

,

renal cell carcinoma

,

liver cirrhosis

,

experimental liver cirrhosis

,

chronic obstructive pulmonary disease

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

ovarian epithelial carcinoma

,

,

colorectal neoplasms

,

pancreatic ductal carcinoma

,

gastrointestinal neoplasms

,

biliary tract neoplasms

,

non-small-cell lung carcinoma

,

,

,

,

acquired immunodeficiency syndrome

,

ovarian neoplasms

,

breast neoplasms

,

,

hepatocellular carcinoma

,

,

immunologic deficiency syndromes

,

,

antibiotic prophylaxis

,

,

chronic hepatitis b

,

uterine cervical neoplasms

,

condylomata acuminata

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

cystic fibrosis

,

pulmonary hypertension

,

pulmonary arterial hypertension

,

endometrial neoplasms

,

,

triple negative breast neoplasms

,

,

chronic hepatitis c

,

,

,

,

,

neuromuscular blockade

,

chronic kidney failure

,

kidney diseases

,

chronic hepatitis

,

,

intestinal diseases

,

non-hodgkin lymphoma

,

,

,

traumatic brain injuries

,

brain concussion

,

,

post-concussion syndrome

disorders of excessive somnolence

,

,

,

,

sleep wake disorders

,

idiopathic hypersomnia

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use